Gastrointestinal Cancer,Pancreatic Cancer NCI-MATCH Phase II: Tolerable TRAEs from Vismdegib Oral Intake Mar 27, 2023
Gastrointestinal Cancer,Pancreatic Cancer Phase 2 eNRGy Study: Zenocutuzumab for NRG1+ Cancers Assessment Mar 27, 2023
Gastrointestinal Cancer,Pancreatic Cancer Phase 2 Study: Rucaparib-resistant BRCA/PALB2 Pancreatic Cancer Treatment Mar 27, 2023
Gastric Cancer,Gastrointestinal Cancer Impact of Skipping Bevacizumab on IMBRAVE150 HCC Treatment Efficacy Mar 14, 2023
Colorectal Cancer,Gastrointestinal Cancer Breakwater Safety Lead-In Improves Outcomes in BRAFV600E mCRC Mar 13, 2023
Colorectal Cancer,Gastrointestinal Cancer Global Study Shows Fruquintinib Improves HRQoL in FRESCO-2 Trial Mar 13, 2023
Colorectal Cancer,Gastrointestinal Cancer EPOCH Trial: Optimizing Treatment Planning for Patient Subgroups Mar 13, 2023
Colorectal Cancer,Gastrointestinal Cancer KEYNOTE-158 Trial: Pembrolizumab Monotherapy in Advanced Thyroid Cancer Patients Mar 10, 2023
